Comparing Motus GI (NASDAQ:MOTS) and Retractable Technologies (NYSE:RVP)

Profitability

This table compares Motus GI and Retractable Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Motus GI	N/A	N/A	N/A
Retractable Technologies	-41.11%	-17.15%	-9.33%

Volatility and Risk

Motus GI has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.

Earnings & Valuation

This table compares Motus GI and Retractable Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Motus GI	$319,000.00	0.00	-$12.87 million	($15.64)	N/A
Retractable Technologies	$33.75 million	0.71	-$7.01 million	($0.77)	-1.03

Retractable Technologies has higher revenue and earnings than Motus GI. Retractable Technologies is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

20.1% of Motus GI shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Comparatively, 57.1% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

About Motus GI

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.